Search Login Register

Disorders of Sex Development (Intersexuality) Summary

Description: In gonochoristic organisms, congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical. Effects from exposure to abnormal levels of GONADAL HORMONES in the maternal environment, or disruption of the function of those hormones by ENDOCRINE DISRUPTORS are included.

Also Known As: Intersexuality; Ambiguous Genitalia; Genital Ambiguity; Hermaphroditism; Intersex Conditions Show All >>

Networked: 514 relevant articles (7 outcomes, 27 trials/studies) for this Disease

Key Drugs and Agents for Disorders of Sex Development

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Dexamethasone (Maxidex) : 3 outcomes in 13 results : FDA 77 Generic
  2. Testosterone (Sustanon) : 1 outcome 2 studies in 41 results : FDA 13
  3. Hormones : 1 outcome 2 studies in 34 results : IBA
  4. Cosmetics : 1 outcome in 14 results : IBA
  5. Brilliant Cresyl Blue : 1 outcome in 1 result : IBA
  6. Penis agenesis : 3 studies in 31 results : IBA
  7. DNA (Deoxyribonucleic Acid) : 3 studies in 9 results : IBA
  8. Complement System Proteins (Complement) : 2 studies in 7 results : IBA
  9. Androgen Receptors (Androgen Receptor) : 1 study in 21 results : IBA
  10. Aromatase (CYP19) : 1 study in 11 results : IBA
Show All >>

Diseases Related to Disorders of Sex Development

  1. Cryptorchidism (Undescended Testes)
  2. Gonadal Dysgenesis (Gonadal Agenesis)
  3. Ovotesticular Disorders of Sex Development
  4. Androgen-Insensitivity Syndrome (Testicular Feminization)
  5. Neoplasms (Cancer)
Show All >>

Key Therapies for Disorders of Sex Development

Efficacy Chart >>
  1. Prosthesis Implantation : 1 study in 1 result
  2. Transplants (Transplant) : 5 results
  3. Castration : 4 results
  4. Laparotomy : 3 results
  5. Female Circumcision (Infibulation) : 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.